Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
Marsh & McLennan Companies is under fresh scrutiny after a modest trim in its fair value estimate, with the target easing from about US$206.40 to roughly US$203.67, a move of around 1%. This adjustment sits alongside a mix of analyst views, where some see the recent share reset and balance sheet strength as appealing, while others point to AI related pressures and slower growth assumptions as reasons for reduced targets and more neutral stances. As you read on, you will see how these shifting calls shape the evolving story around the stock and what that might mean for your watchlist.
Raymond James upgraded Marsh & McLennan to Strong Buy from Outperform, highlighting what it sees as a high quality earnings profile, consistent margin expansion, and credit metrics it views as among the strongest in the peer group.
Raymond James set a price target of US$225, down from US$240, and cited the recent valuation reset, limited exposure to Howden related litigation, and industry low CDS spreads as support for what it views as an attractive risk reward setup.
Barclays, which trimmed its target to US$209 from US$210, kept an Overweight rating and argued that the share pullback has more than reflected slower growth assumptions while not fully reflecting the broker model and AI as a potential productivity enabler.
Mizuho cut its rating to Neutral from Outperform with a target of US$199, reduced from US$213, signaling a more cautious stance on the stock even as it maintains coverage.
JPMorgan, BofA, Morgan Stanley, Mizuho, and Keefe Bruyette all lowered price targets in recent months, indicating some concern around execution and growth assumptions, including the impact of AI related disruption on the sector.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives!
NYSE:MRSH 1-Year Stock Price Chart
We’ve flagged 2 risks for Marsh & McLennan Companies. See which could impact your investment.
Marsh & McLennan Companies completed repurchases of 5,966,291 shares, or 1.23% of shares, for US$1,074.65m under the buyback announced on November 20, 2025, including 4,191,817 shares, or 0.86%, for US$750m in the first quarter of 2026.
Under the buyback announced on November 9, 2010, the company repurchased a total of 152,429,637 shares, or 29.16%, for US$13.12b, including 3,671,426 shares, or 0.75%, for US$675.35m from October 1, 2025 to November 20, 2025.
The company indicated that, based on its outlook for 2026, about US$5b of capital is expected to be deployed across dividends, acquisitions and share repurchases, with the level of buybacks depending on how the M&A pipeline develops.
Marsh McLennan Agency launched Secure Harbor, a group captive insurance company for skilled nursing, assisted living and senior living communities, providing general and professional liability coverage and access to captive risk and senior care expertise.
Story Continues
Fair value trimmed from about US$206.40 to about US$203.67, a move of roughly 1%.
Revenue growth revised from about 4.98% to about 4.36%.
Net profit margin adjusted from about 18.00% to about 17.75%.
Future P/E eased from about 20.65x to about 20.21x.
Discount rate effectively unchanged at about 6.98%.
Narratives link a company’s business story, industry context, and risk profile to the earnings forecasts and fair value models analysts are using. They refresh as new data, research, and company announcements come through so you can see how the thesis evolves over time.
Head over to the Simply Wall St Community and follow the Narrative on Marsh & McLennan Companies to stay up to date on:
How growing global risk complexity, tighter regulation, and a larger insured middle class are feeding demand for Marsh & McLennan’s risk, insurance, and people advisory services.
The role of digital investments, advanced analytics, AI tools, and acquisitions such as McGriff in broadening the business and shaping earnings potential.
Key risks around softer insurance pricing, pressure on discretionary consulting, acquisition integration, higher liability costs, and technology driven disruption of traditional brokerage models.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include MRSH.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com